TrialHepatology international2022

Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.

Yan Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.